Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI

Medical - Devices

Healthcare
$14.01 +7.25%

+$0.84 today

Market cap
$1.35B
Beta
2.18
P/E (TTM)
-34.3
EPS (TTM)
-$0.28
52W Low $6.45High $19.45

Volume 0.26M

Average 0.92M

LMRI Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Lumexa Imaging Holdings, Inc. Common StockNASDAQ: LMRI

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation of $12.27M in Q1 FY2026

Q1 FY2026 stock-based compensation was $12.27M.

Context

  • Stock-based compensation amounted to 4.1% of revenue in FY2025, down 1.9 pp from a year earlier.
  • Stock-based compensation increased in 1 of the last 2 fiscal years.
  • FY2025 was the lowest annual figure in the 3 fiscal years shown.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$12.27M-33.9% QoQ
Last fiscal yearDec 2025
$41.6M-26.6% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-26.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
41.6M USD
Year-over-year change
-26.6%
2-year CAGR
-13.3%

Stock-Based Compensation vs competitors

How LMRI compares with its peers on the latest reported figures

  • LMRI's FY2025 stock-based compensation of $41.6M is the smallest of the 2 companies compared; the peer median is $60.26M.
  • Its year-over-year change of -26.6% is the lowest of 2, against a peer median of +10.1%.
  • Stock-based compensation amounts to 4.1% of revenue for LMRI, versus a peer median of 2.5%.
LMRI Competitors Peer median
Stock-Based Compensation for LMRI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RDNTRadNet, Inc.LTM Sep 2026$60.26M +10.1%+31.9%2.5%
LMRILumexa Imaging Holdings, Inc. Common StockFY2025$41.6M -26.6%—4.1%
Peer median (excluding LMRI) $60.26M+10.1%+31.9%2.5%

Competitors are the stored peer set for LMRI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(122.23M)(94.1M)(47.1M)
Depreciation & Amortization72.14M57.16M55.39M
Deferred Income Tax611K9.75M8.08M
Stock-Based Compensation55.3M56.65M41.6M
Change in Working Capital(4.14M)(2.6M)(44.35M)
Accounts Receivables(15.3M)(5.32M)(14.01M)
Inventory000
Accounts Payables4.76M2.95M14.42M
Other Working Capital6.4M(225K)(44.75M)
Other Non-Cash Items35.83M13.86M3.46M
Operating Cash Flow37.51M40.73M17.07M
Capital Expenditures(24.01M)(27.77M)(23.48M)
Acquisitions (Net)(5.65M)5.13M2.64M
Purchases of Investments00(123K)
Sales of Investments000
Other Investing Activities0361K0
Investing Cash Flow(29.66M)(22.28M)(20.96M)
Debt Repayment(10.91M)(12.67M)(392.83M)
Common Stock Issued2.26M673K427.81M
Common Stock Repurchased(118K)00
Dividends Paid000
Other Financing Activities0(506K)1.6M
Financing Cash Flow(8.77M)(12.5M)36.58M
Effect of Forex Changes000
Net Change in Cash(912K)5.95M32.7M
Free Cash Flow13.51M12.95M(6.4M)

Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI

Intrinsic Alpha fair value

Locked

Current Price

$14.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.